1. Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data. (March 2022) Authors: Younan, Helen-Cara; Zhang, Shuai; Monroy, Maria; Almusarhed, Manar; Julve, Max; Roy, Debashree; Toghey, Sopozme; Ahmed, Zartaj; Slater, Stephanie; Altharwane, Shaymaa; Giorgiou, Alex; Ghosh, Sharmistha; Gennatas, Spyridon; Karapanagiotou, Eleni; Montes, Ana; Pintus, Elias; Spicer, James; Shah, Ri... Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Protocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR). Issue 11 (21st November 2016) Authors: Harris, Dean A; Thorne, Kymberley; Hutchings, Hayley; Islam, Saiful; Holland, Gail; Hatcher, Olivia; Gwynne, Sarah; Jenkins, Ian; Coyne, Peter; Duff, Michael; Feldman, Melanie; Winter, Des C; Gollins, Simon; Quirke, Phil; West, Nick; Brown, Gina; Fitzsimmons, Deborah; Brown, Alan; Beynon, John Journal: BMJ open Issue: Volume 6:Issue 11(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2019) Authors: Nakagawa, Kazuhiko; Garon, Edward B; Seto, Takashi; Nishio, Makoto; Ponce Aix, Santiago; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh, Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Enatsu, Sotaro; Zimmermann, Annamaria; Frimod... Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience. (June 2021) Authors: Ravindra, Saranya; Murphy, Ravindhi; Ferjani, Isra; Clark, James; Ahmed, Dalia; Power, Danielle; Hatcher, Olivia; Mohammed, Waleed; Newsom-Davis, Tom; Evans, Joanne Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗